U-Blot® Research Grade Anti-pan SARS-CoV-2 S2/Spike glycoprotein 2 Antibody (CC99.103)Cat. No. WA2344$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-pan SARS-CoV-2 S2/Spike glycoprotein 2 Antibody (CC99.103)Cat. No. WA2344
U-Blot® Research Grade Anti-pan SARS-CoV-2 S2/Spike glycoprotein 2 AntibodyCat. No. WA2343
U-Blot® Research Grade Anti-Orthohantavirus puumalaense GP Antibody (ADI-65534)Cat. No. WA2342
U-Blot® Research Grade Anti-Orthohantavirus puumalaense GP Antibody (ADI-65533)Cat. No. WA2341
U-Blot® Research Grade Anti-Orthohantavirus puumalaense GP Antibody (ADI-42898)Cat. No. WA2340
U-Blot® Research Grade Anti-MERS-CoV Spike Protein Antibody (3A1)Cat. No. WA2339
U-Blot® Research Grade Anti-MERS-CoV RBD Antibody (REGN3051)Cat. No. WA2338
U-Blot® Research Grade Anti-LPA/Lysophosphatidic acid Antibody (LT3015)Cat. No. WA2337
U-Blot® Research Grade Anti-LPA/Lysophosphatidic acid Antibody (504B3)Cat. No. WA2336
U-Blot® Research Grade Anti-LILRB1 & LILRB2 Bispecific Antibody (Ngm707)Cat. No. WA2335
U-Blot® Research Grade Anti-LAG-3 & PD-1 Bispecific Antibody (Emb-02)Cat. No. WA2334
U-Blot® Research Grade Anti-Influenza A virus HA/Hemagglutinin Broad-Neutralizing Antibody (CR9114)Cat. No. WA2333